Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.

about

Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria.Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey.

P2860

Q43240579-6CCE69CA-3A6C-4276-9AAC-94B51C5A7517 Q46731211-93B0F29E-7AE5-44FF-ABB7-05B7CE73F405

P2860

Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.

Item

http://www.wikidata.org/entity/Q47628139

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@en

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@nl

type

Item

label

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@en

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@nl

prefLabel

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@en

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@nl

P1476

Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.

@en

P2093

Alessandro Capucci

http://www.w3.org/2001/XMLSchema#string

Domenico Gabrielli

http://www.w3.org/2001/XMLSchema#string

Federico Guerra

http://www.w3.org/2001/XMLSchema#string

Jenny Ricciotti

http://www.w3.org/2001/XMLSchema#string

Luca Piangerelli

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol

Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supra

Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life.

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study.

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.

P304

1698-1704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EUROPACE/EUV462

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295074372

http://www.w3.org/2001/XMLSchema#string

P698

26893497

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.

about

P2860

P2860

Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921